N-CBZ-4-哌啶甲醇(1-CBZ-4-羟甲基哌啶), 98%,Benzyl 4-(hydroxymethyl)piperidine-1-carboxylate

产品编号:西域试剂-WR129907| CAS NO:122860-33-7| 分子式:C14H19NO3| 分子量:249.31

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
西域试剂-WR129907
45.00 杭州 北京(现货)
西域试剂-WR129907
208.00 杭州 北京(现货)
西域试剂-WR129907
741.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

英文名称Benzyl 4-(hydroxymethyl)piperidine-1-carboxylate
CAS编号122860-33-7
产品沸点396.4±25.0 °C at 760 mmHg
产品密度1.2±0.1 g/cm3
产品闪点193.5±23.2 °C
精确质量249.136490
PSA49.77000
LogP1.50
蒸气压0.0±1.0 mmHg at 25°C
折射率1.550

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


危害码 (欧洲) Xi: Irritant;
风险声明 (欧洲) R36/37/38
安全声明 (欧洲) 26-36/37/39-37/39
海关编码 2933399090
Name: Benzyl 4-(hydroxymethyl)tetrahydro-1(2H)-pyridinecarboxylate 95+% Material Safety Data Sheet
Synonym: 4-Hydroxymethylpiperidine-1-carboxylic acid benzyl este
CAS: 122860-33-7
Section 1 - Chemical Product MSDS Name:Benzyl 4-(hydroxymethyl)tetrahydro-1(2H)-pyridinecarboxylate 95+% Material Safety Data Sheet
Synonym:4-Hydroxymethylpiperidine-1-carboxylic acid benzyl este

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
122860-33-7 Benzyl 4-(hydroxymethyl)tetrahydro-1(2 95+% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 122860-33-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Viscous liquid
Color: yellow
Odor: pleasant odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C14H19NO3
Molecular Weight: 249

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 122860-33-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Benzyl 4-(hydroxymethyl)tetrahydro-1(2H)-pyridinecarboxylate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 122860-33-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 122860-33-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 122860-33-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

~90%

122860-33-7结构式

122860-33-7

文献:INSTITUT PASTEUR KOREA; KIM, Junwon; CECHETTO, Jonathan; NO, Zaesung; CHRISTOPHE, Thierry; KIM, Taehee; NAM, Ji, Youn; SO, Wonyoung; JO, Mina; OK, Taedong; PARK, Changmin; SEO, Min, Jung; SOHN, Jeong-Hun; SOMMER, Peter; BOESE, Annette, Sophia; HAN, Sung-Jun; PARK, Young, Sam; KIM, Hwa, Pyung Patent: WO2010/46780 A2, 2010 ; Location in patent: Page/Page column 63-64 ;

~44%

122860-33-7结构式

122860-33-7

文献:SmithKline Beecham plc Patent: EP1051413 B1, 2003 ;

~45%

122860-33-7结构式

122860-33-7

文献:Fang, Xinqin; Garvey, David S.; Gaston, Ricky D.; Lin, Chia-En; Ranatunga, Ramani R.; Richardson, Stewart K.; Wang, Tiansheng; Wang, Weiheng; Wey, Shiow-Jyi Patent: US2003/203915 A1, 2003 ;

~91%

122860-33-7结构式

122860-33-7

文献:Sterling Winthrop Inc. Patent: US5512589 A1, 1996 ; US 5512589 A

~%

122860-33-7结构式

122860-33-7

文献:Journal of Medicinal Chemistry, , vol. 48, # 10 p. 3586 - 3604

~%

122860-33-7结构式

122860-33-7

文献:US4968704 A1, ;

~%

122860-33-7结构式

122860-33-7

文献:Chinese Chemical Letters, , vol. 23, # 6 p. 661 - 664

~85%

122860-33-7结构式

122860-33-7

文献:NEUROSEARCH A/S Patent: WO2007/93603 A1, 2007 ; Location in patent: Page/Page column 15 ; WO 2007/093603 A1

~%

122860-33-7结构式

122860-33-7

文献:Tetrahedron Letters, , vol. 48, # 2 p. 199 - 202

服务热线

13911702513
18601927057

微信客服